The estimated Net Worth of Christopher Koster is at least $9.88 Millón dollars as of 28 October 2021. Mr. Koster owns over 14,300 units of Centene stock worth over $8,871,723 and over the last 5 years he sold CNC stock worth over $1,003,431. In addition, he makes $0 as Senior Vice President, General Counsel y Secretary at Centene.
Sign up
Mr. Koster CNC stock SEC Form 4 insiders trading
Christopher has made over 1 trades of the Centene stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 14,300 units of CNC stock worth $1,003,431 on 28 October 2021.
The largest trade he's ever made was selling 14,300 units of Centene stock on 28 October 2021 worth over $1,003,431. On average, Christopher trades about 715 units every 0 days since 2020. As of 28 October 2021 he still owns at least 120,753 units of Centene stock.
You can see the complete history of Mr. Koster stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Christopher Koster biography
Christopher A. Koster serves as Senior Vice President, General Counsel, Secretary of the Company. Mr. Koster has served as Senior Vice President, Corporate Services since 2017. Prior to joining Centene, Mr. Koster served as Missouri Attorney General for eight years.
How old is Christopher Koster?
Christopher Koster is 55, he's been the Senior Vice President, General Counsel y Secretary of Centene since 2020. There are 16 older and 14 younger executives at Centene. The oldest executive at Centene Corp. is Robert Ditmore, 86, who is the Presiding Independent Director.
What's Christopher Koster's mailing address?
Christopher's mailing address filed with the SEC is 7700, Forsyth Boulevard, Clayton, Saint Louis County, Missouri, 63105, United States.
Insiders trading at Centene
Over the last 21 years, insiders at Centene have traded over $221,714,329 worth of Centene stock and bought 119,005 units worth $6,904,837 . The most active insiders traders include Frederick H Eppinger, Michael F Neidorff y Edward L Cahill. On average, Centene executives and independent directors trade stock every 18 days with the average trade being worth of $1,257,880. The most recent stock trade was executed by Christopher J Coughlin on 14 May 2024, trading 878 units of CNC stock currently worth $67,387.
What does Centene do?
centene corporation, a fortune 500 company, is a diversified, multi-national healthcare enterprise that provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. many receive benefits provided under medicaid, including the state children's health insurance program (chip), as well as aged, blind or disabled (abd), foster care and long term care (ltc), in addition to other state-sponsored/hybrid programs, and medicare (special needs plans). the company operates local health plans and offers a range of health insurance solutions. it also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health management, care management software, correctional healthcare services, dental benefits management, in-home health services, life and health management, managed vision, pharmacy benefits management, specialty pharmacy and telehealth services.
What does Centene's logo look like?
Complete history of Mr. Koster stock trades at Centene
Centene executives and stock owners
Centene executives and other stock owners filed with the SEC include:
-
Michael Neidorff,
Chairman of the Board, President, Chief Executive Officer -
Jeffrey Schwaneke,
Chief Financial Officer, Executive Vice President, Treasurer -
Brandy Burkhalter,
Executive Vice President - Operations -
Michael Frederic Neidorff,
Chairman & CEO -
Jesse Hunter,
Executive Vice President and Chief Strategy Officer -
Mark Brooks,
Executive Vice President, Chief Information Officer -
Jeffrey Alan Schwaneke CPA, CPA,
Exec. VP, CFO & Treasurer -
Keith Williamson,
Executive Vice President, General Counsel, Secretary -
Brandy Lynn Burkhalter,
Exec. VP -
Mark J. Brooks,
Exec. VP & Chief Information Officer -
Frederick Eppinger,
Independent Director -
John Roberts,
Independent Director -
Robert Ditmore,
Presiding Independent Director -
David Steward,
Independent Director -
Tommy Thompson,
Independent Director -
Jessica Blume,
Independent Director -
Orlando Ayala,
Independent Director -
Lori Robinson,
Independent Director -
Richard Gephardt,
Independent Director -
William Trubeck,
Independent Director -
H. James Dallas,
Independent Director -
Jennifer Gilligan,
Senior Vice President of Investor Relations -
Christopher Koster,
Senior Vice President, General Counsel, Secretary -
Christopher Isaak,
Senior Vice President, Corporate Controller and Chief Accounting Officer -
Jonathan Dinesman,
Executive Vice President - Government Relations -
Kenneth Burdick,
Executive Vice President - Markets & Products -
H. Robert Sanders,
Executive Vice President of Human Resources -
Shannon Bagley,
Executive Vice President of Human Resources -
David Thomas,
Executive Vice President - Marketing -
Katie Nicole Casso,
Sr. VP, Chief Accounting Office & Corp. Controller -
Christopher Andrew Koster,
Sr. VP, Gen. Counsel & Sec. -
Katie Casso,
Sr. VP, Chief Accounting Office & Corp. Controller -
Andrew Lynn Asher,
Exec. VP & CFO -
Brent Davis Layton,
Pres & COO -
Sarah M. London,
Pres of Health Care Enterprises & Exec. VP of Advanced Technology & Vice Chairman -
Patrick John Rooney,
Sr. VP of Health Plans -
Matthew Snyder,
Sr. VP of Internal Audit, Compliance & Risk Management -
Christopher Russell Isaak B.B.A., CPA,
Sr. VP, Corp. Controller & Chief Accounting Officer -
Monte E Ford,
Director -
Cynthia J Brinkley,
EVP, International Operations -
Christopher D Bowers,
EVP, Markets -
Carol Goldman,
Sr VP Chief Admin Officer -
Kenneth Rone Baldwin,
EVP, Insurance Group -
James E Murray,
EVP, Chief Operating Officer -
Donald G Imholz,
SVP, Chief Information Officer -
William Scheffel,
Senior VP and Controller -
Pamela A Joseph,
Director -
Vicki B Escarra,
Director -
Leslie V Norwalk,
Director -
Christopher J Coughlin,
Director -
Theodore R. Ii Samuels,
Director -
Wayne S De Veydt,
Director -
Catherine M Halverson,
Senior VP Business Development -
Edmund E Kroll,
SVP Fin & Investor Relations -
Brian G Spanel,
Senior Vice President and CIO -
Karen Bedell,
SVP New Bus Integ & Develop -
Robert T Hitchcock,
EVP Health Plans -
Cary Hobbs,
Sr VP Strategy and Imp. -
Marie J Glancy,
VP Government Relations -
Jason M Harrold,
SVP, Specialty Business Unit -
Karey L Witty,
Senior Vice President and CFO -
J Per Brodin,
Senior Vice President and CFO -
Eric Slusser,
Executive VP & CFO -
Patti Darnley,
Sr. VP of Operations -
Lisa M Wilson,
VP Investor Relations -
Mark W Eggert,
Executive VP, Health Plans -
Mary V Mason,
SVP & Chief Medical Officer -
Edward L Cahill,
Director -
Frederick J Manning,
Executive Vice President -
Richard P Wiederhold,
Director -
James D Jr Donovan,
Senior VP Product Development -
Steve Bartlett,
Director -
C David Minifie,
EVP, Chief Marketing Officer -
Glendon A Schuster,
Senior VP and CIO -
Samuel E Bradt,
Director -
Antonette Simonetti,
SVP, Public Affairs -
Joseph P Jr Drozda,
Executive VP Operations -
John Tadich,
Senior VP, Specialty Companies -
Claire W Johnson,
Director -
Dan Paquin,
Sr. VP New Plan Implementation -
Andrew Lynn Asher,
Chief Financial Officer -
Susan Raye Smith,
Chief Operating Officer -
Brent D Layton,
President & COO -
Sarah London,
Chief Executive Officer -
Colin A Toney,
EVP, Mergers & Acquisitions -
Katie Casso,
Corporate Controller & CAO -
Kenneth J Fasola,
President